U.S. Patent and Trademark Office (USPTO) — Organization, Functions & Policy Role

The U.S. Patent and Trademark Office (USPTO) is the federal agency responsible for granting patents and registering trademarks — two of the most economically consequential government functions in the American innovation economy. Established by Congress under the constitutional authority to "promote the Progress of Science and useful Arts" (Article I, § 8, cl. 8), the USPTO is one of the oldest federal agencies, tracing its origins to the Patent Act of 1790. Today it employs approximately 13,000 people — mostly patent examiners with technical degrees — and operates as a fully fee-funded agency: unlike most federal agencies, the USPTO does not receive general Treasury appropriations but is funded entirely by the fees paid by applicants, patent holders, and trademark registrants.

The USPTO processes roughly 650,000 patent applications and 550,000 trademark applications per year, generating approximately $4.5 billion in fee revenue annually. Its decisions shape the competitive landscape of every technology-intensive industry — from pharmaceutical drug patents that determine generic drug availability, to software patents that affect the tech sector, to trademark registrations that define brand protection rights globally.

Current Law (2026)

Legal Authority

• 35 U.S.C. § 1 — Establishment: there is established in the Department of Commerce a United States Patent and Trademark Office, which shall be responsible for the granting and issuing of patents and the registration of trademarks
• 35 U.S.C. § 3 — Director of the USPTO: the Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office shall be a citizen of the United States who has a professional background and experience in patent or trademark law; appointed by the President with the advice and consent of the Senate
• 35 U.S.C. § 6 — Patent Trial and Appeal Board: the PTAB shall consist of the Director, the Deputy Director, the Commissioner for Patents, the Commissioner for Trademarks, and administrative patent judges; conducts inter partes review, post-grant review, and derivation proceedings; decides ex parte appeals from patent prosecution
• 35 U.S.C. § 10 — Fee setting authority: the Director shall set or adjust fees for all patent processing, searching, examining, issuing, and maintaining functions; fees set to recover aggregate estimated costs; the AIA granted the USPTO authority to set its own fees without going through the full Congressional appropriations process
• 35 U.S.C. § 41 — Patent fees: filing fees, search fees, examination fees, issue fees, maintenance fees — these periodic payments are what sustain USPTO operations; maintenance fees paid at 3.5, 7.5, and 11.5 years after issuance are substantial revenue sources and also result in many patents lapsing when owners choose not to pay
• 15 U.S.C. § 1051 — Trademark registration authority: the Director of the USPTO shall register trademarks on the Principal Register for marks in use in commerce that meet the statutory requirements; the USPTO administers the federal trademark registration system
• 35 U.S.C. § 311, 321 — PTAB jurisdiction over inter partes review (IPR) and post-grant review (PGR): the PTAB adjudicates challenges to patent validity brought by third parties; IPR is limited to prior art grounds; PGR allows any invalidity ground if filed within 9 months of patent issuance

Organization

Office of the Director

The Director of the USPTO (officially the Under Secretary of Commerce for Intellectual Property and Director of the USPTO) is the agency's chief executive, appointed by the President with Senate confirmation. The Director sets patent and trademark policy, manages the agency's budget and operations, and represents the U.S. in international IP policy forums (including the World Intellectual Property Organization, WIPO). The Director testifies to Congress on patent reform legislation and issues guidance on patent examination policies (including subject matter eligibility guidance following Alice and Mayo). The position carries significant policy power — USPTO guidance documents, while not legally binding in courts, shape how thousands of examiners evaluate the roughly 650,000 applications filed each year.

Patent Division

The Patent Division employs approximately 8,000 patent examiners organized by technology center — groups specializing in specific technical areas (biotechnology, chemistry, computer science, electrical engineering, mechanical engineering, etc.). Examiners hold technical degrees (bachelor's through doctorate) in their specialty areas. The average patent application takes approximately 24-30 months from filing to disposition (grant or final rejection). The backlog of unexamined applications has been a persistent challenge, with approximately 700,000 applications pending at any given time.

Key Patent Division functions:

• Examination: Reviewing applications for compliance with patentability requirements (§§ 101-103, 112)
• Prior art search: Searching USPTO databases and external sources for relevant prior art
• Appeals: The Patent Trial and Appeal Board (PTAB) hears appeals from examiner final rejections (ex parte appeals) and handles inter partes proceedings (IPR and PGR)
• International: Processing Patent Cooperation Treaty (PCT) international applications as the Receiving Office and International Searching Authority
• Publication: Publishing applications 18 months after filing; maintaining public patent databases

Trademark Division

The Trademark Division employs approximately 1,600 trademark examining attorneys who review applications for compliance with registration requirements (distinctiveness, no likelihood of confusion with existing marks, etc.). The trademark examination process typically takes 8-12 months for straightforward applications. The Trademark Trial and Appeal Board (TTAB) handles:

• Opposition proceedings: Third parties opposing trademark registration (must be filed within 30 days of publication for opposition)
• Cancellation proceedings: Challenging registrations that are already on the Principal Register
• Ex parte appeals: Appeals from examining attorney refusals

Patent Trial and Appeal Board (PTAB)

Created by the America Invents Act (2011), the PTAB is the USPTO's administrative adjudicatory body for patent validity challenges. The PTAB consists of Administrative Patent Judges (APJs) — patent attorneys with technical backgrounds who are employed by the USPTO. PTAB proceedings include:

• Inter Partes Review (IPR): Challenges to patent validity based on prior art patents and publications; available after patent issuance; petitioner must demonstrate a "reasonable likelihood" that at least one claim is unpatentable; IPR has been used extensively by defendants in patent litigation
• Post-Grant Review (PGR): Challenges on any invalidity ground; must be filed within 9 months of patent issuance; higher threshold to institute (petitioner must show it is "more likely than not" that at least one claim is unpatentable)
• Covered Business Method (CBM) Review: A transitional program created by AIA for business method patents (now expired for new petitions)
• Derivation Proceedings: Disputes between applicants claiming the same invention was derived from the other

The PTAB has been controversial: patent challengers (typically defendants in infringement suits) view it as an efficient tool to weed out invalid patents; patent holders (including small inventors and pharmaceutical companies) have criticized it as a "patent death squad" that makes it too easy to invalidate legitimately issued patents. Multiple PTAB reform proposals have been debated in Congress.

Trademark Trial and Appeal Board (TTAB)

The TTAB adjudicates trademark registration disputes. Its decisions on likelihood of confusion, descriptiveness, and genericness create precedent for trademark examination practice. TTAB decisions can be appealed to federal district courts or the Federal Circuit Court of Appeals.

The Fee-Funded Model

The USPTO's fee-funded structure is unusual among federal agencies. All operational costs are paid from fees charged to applicants and patent/trademark holders:

• Utility patent filing fee: $1,720 (large entity); $860 (small entity: fewer than 500 employees or certain universities); $430 (micro entity: individuals/small businesses meeting income/application count criteria)
• Maintenance fees: Due at 3.5, 7.5, and 11.5 years after patent issuance; large entity rates of $2,000 / $3,760 / $7,700. Approximately 50% of patents lapse for failure to pay maintenance fees — owners who determine a patent is no longer worth maintaining stop paying, and the patent falls into the public domain.
• Trademark registration: $250-350 per class of goods/services for electronic filing
• PTAB IPR filing: $19,500 (up to 20 claims); additional fees per additional claim

The America Invents Act (2011) granted the USPTO authority to set its own fees without going through the appropriations process, ensuring that fee revenues stay with the office rather than being diverted to the general Treasury (as they had been in prior decades). This "fee diversion" problem — where Congress took USPTO fee revenue to fund other government operations — had contributed to examiner backlogs and was resolved by the AIA's fee-setting authority.

How It Affects You

If you're an inventor, startup, or small business: The USPTO's fee schedule includes discounts for small entities (50% reduction) and micro entities (80% reduction) — these apply to applicants with fewer than 500 employees (small entity) or individuals/businesses meeting income and prior-application limits (micro entity). Using these fee categories is important for managing IP costs. Key practical points: the USPTO's Patent Pro Bono Program matches financially under-resourced inventors with volunteer patent attorneys and agents who provide free prosecution assistance. The Law School Clinic Certification Program allows law students under faculty supervision to prosecute patent applications. For trademarks, the Trademark Electronic Application System (TEAS) at USPTO.gov allows online filing — the TEAS Plus form (requiring selection from an existing identification manual) is $250/class vs. TEAS Standard at $350/class. Before spending money on a patent application, run a prior art search through Google Patents, USPTO's Patent Full-Text Database, or Espacenet (EPO's global patent database) to assess likelihood of getting a patent on your concept.

If you're challenging a patent that's being used against you: The PTAB's Inter Partes Review (IPR) process typically costs $75,000-$200,000 through final decision — dramatically less than the $3-5 million median cost of patent litigation through trial. IPR is effective: approximately 60% of IPR petitions that are instituted result in cancellation of all challenged claims; many more result in partial cancellation. The IPR petition must be filed within one year of service of an infringement complaint — this deadline is strictly enforced. PTAB proceedings run in parallel with district court litigation; courts may grant stays of district court proceedings pending PTAB outcomes. For pharmaceutical patents, the specialized inter partes review of Orange Book-listed patents intersects with Hatch-Waxman litigation strategy.

If you manage a patent portfolio at a technology company: Annual maintenance fees are the carrying cost of your patent portfolio — a large patent portfolio can cost millions of dollars per year in maintenance fees. Systematic portfolio pruning (deciding which patents are worth renewing and which to let lapse) is important IP management. USPTO fee increases require monitoring; the AIA's fee-setting authority means the Director can raise fees without Congressional action. PTAB statistics (institution rates, cancellation rates by technology area) are publicly available and should inform your assessment of patent vulnerabilities. The USPTO's subject matter eligibility guidance — regularly updated following Alice and Mayo Supreme Court decisions — directly affects the prosecution and validity of software, AI, and diagnostic method patents.

If you work in international trade, diplomacy, or IP policy: The USPTO plays a central role in international IP policy through its participation in WIPO (World Intellectual Property Organization), its bilateral IP negotiations, and its Technical Assistance programs for developing countries. The USPTO's annual "Special 301 Report" (prepared by USTR but with USPTO input) evaluates trading partners' IP protection and enforcement — the report is a significant diplomatic instrument, and being placed on the "Priority Watch List" can trigger trade sanctions. The USPTO's position on issues like patent term, data exclusivity, and trade secret protection shapes U.S. negotiating positions in trade agreements (USMCA, CPTPP, bilateral FTAs). On AI-specific patents: the USPTO issued guidance in 2024 on inventorship for AI-assisted inventions, requiring a human inventor to contribute a "significant contribution" to each patent claim — purely AI-generated inventions are not currently patentable.

State Variations

Patents and federal trademark registration are exclusively federal — state law does not create or govern patents. However:

• State trademark registration: States maintain their own trademark registration systems for marks used only within state commerce. State registrations are cheaper than federal registrations but provide narrower protection (state-only geographic scope, no Lanham Act remedies, no customs recordal for import protection). Most significant marks rely on federal registration.
• State trade secret law: Complementary to patent protection; see Defend Trade Secrets Act for federal overlay.
• Common law trademark rights: Exist in all states through use in commerce, regardless of registration — but provide narrower geographic protection than federal registration.

Recent Developments

• 2024 — AI inventorship guidance: The USPTO issued final guidance stating that AI systems cannot be listed as inventors on patent applications; human inventors must make a "significant contribution" to each claim. This resolved the Thaler v. Vidal question (DABUS AI system denied patent) but left open questions about AI-assisted inventions.
• 2024 — Subject matter eligibility guidance: The USPTO updated its guidance on § 101 subject matter eligibility for AI-related inventions, attempting to provide clearer frameworks for examiners and practitioners. The guidance remains controversial, as the underlying Supreme Court framework (Alice, Mayo) has created persistent uncertainty.
• 2025 — Director vacancy: With the change in administration, the USPTO Director position was vacated and nominees were under consideration, leaving policy direction uncertain during the transition.
• 2025 — Patent Eligibility Restoration Act: Senate bills to reform § 101 subject matter eligibility by replacing the judicially created Alice/Mayo framework with a statutory utility-focused test were reintroduced. If enacted, they would dramatically expand patent eligibility for software and diagnostic methods.
• 2025 — PTAB reform: Ongoing debates about PTAB Director review authority (can the Director review PTAB decisions unilaterally?) and proposed rules changes to PTAB trial procedures continued, reflecting persistent industry disagreement about the optimal balance between patent challenge access and patent holder rights.
• 2025-2026 — Trademark counterfeiting crackdown: The USPTO significantly increased scrutiny of trademark applications from foreign applicants (particularly Chinese applicants), following a surge in fraudulent trademark applications and specimen fraud. New rules require U.S.-licensed attorneys for foreign trademark applicants.